Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eloria vs Wellorithm

Eloria
Graded #214

Higher grade

vs+17.099999999999994
Wellorithm
Graded #486

Lower grade

The verdict

Eloria takes it — 65.6/100 to 48.5/100.

Eloria grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eloria is a clinician-led GLP-1 weight-loss telehealth platform operated by Arora Health & Aesthetics.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEloria +19
49
30
Dose & formulationWellorithm +16
76
92
Clinical oversightEloria +51
79
28
Labs & monitoringEloria +12
52
40
FulfillmentEloria +19
81
62
Contract termsEloria +16
61
45
Eloria · left barWellorithm · right bar

The numbers

MetricEloriaWellorithm
WeighScore65.6/10048.5/100
GradeCC
Scorecard rank#214#486
Semaglutide$179/mo (starting dose, plus a separate fee, compounded)Pricing not published
TirzepatideNot disclosedPricing not published
CoverageCoverage not published49 states (not Louisiana)
Brand-name accessYesYes
Oral / sublingualYesYes
Eloria

Graded #214 · C

Strengths

  • Compounded GLP-1 injections from $179/mo and oral dissolving tablets from $249/mo, with no membership or hidden fees
  • Also offers brand Wegovy (pill or injection) on a $99/mo membership plus medication cost
  • Board-certified providers (via Arora Health & Aesthetics) and US-licensed pharmacies
  • HSA/FSA accepted, free shipping on every order, and 24/7 support
  • Full published compliance suite (Terms, Privacy, Refund, Shipping, Physician Code of Conduct, Consent to Telehealth)

Where it loses points

  • Compounded medications are not FDA-approved - not brand Ozempic, Zepbound, or Mounjaro
  • State availability varies and is not published - only where providers are licensed and pharmacies can dispense
  • The compounding pharmacy partner is not named (US-licensed pharmacies only)
  • No LegitScript certification displayed
  • Brand Wegovy uses a separate $99/mo membership-plus-medication-cost model
Wellorithm

Graded #486 · C

Strengths

  • Both molecules in BOTH routes — compounded semaglutide and tirzepatide as injections and as oral dissolving tablets
  • Four branded pens on the same account: Mounjaro, Ozempic, Wegovy and Zepbound
  • Sermorelin offered alongside the GLP-1 line
  • 24/7 phone support on a published number

Where it loses points

  • No price appears anywhere on the public site — /pricing 404s and every product CTA leads to a 2-minute intake quiz, so no cost can be compared before signing up
  • The site contradicts itself on coverage: the homepage says "Serving All 50 States" while its own FAQ says 49 states and excludes Louisiana
  • The four clinicians presented as "board-certified obesity specialists" are listed as Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
  • "100% Customer Satisfaction" is stated as a headline fact and is not a substantiable claim

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard